Curis, Inc. (CRIS) vs GeoVax Labs, Inc. (GOVX)
A side-by-side comparison of Curis, Inc. and GeoVax Labs, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CRIS
Curis, Inc.
$0.75HealthcareDelayed quote: Oct 6, 2026, 12:52 PM EDT
GOVX
GeoVax Labs, Inc.
$0.31HealthcareDelayed quote: Oct 6, 2026, 1:05 PM EDT
Total return — CRIS vs GOVX
growth of $100 · dividends reinvested · last 10yCRIS -81.3% (-15.5%/yr)GOVX -100.0% (-77.3%/yr)CRIS compounded faster over this window
Log scale — wide-divergence pair
CRIS GOVX
CRIS vs GOVX: by the numbers
- •GOVX is the larger company ($2M vs $1M market cap).
- •Both run net losses; CRIS's is the smaller (-490.33% vs -862.34% net margin).
Metrics side by side
Valuation
| Metric | CRIS | GOVX |
|---|---|---|
| P/S ratio | 0.34 | N/A |
| P/B ratio | 0.31 | 1.29 |
Profitability
| Metric | CRIS | GOVX |
|---|---|---|
| Gross margin | 99.28% | -628.02% |
| Operating margin | -348.43% | -869.34% |
| Net margin | -490.33% | -862.34% |
| ROE | -450.54% | -1160.10% |
| ROIC | -567.17% | -985.20% |
Growth (annualized)
| Metric | CRIS | GOVX |
|---|---|---|
| Revenue CAGR (5Y) | -15.88% | N/A |
| Total return CAGR (5Y) | -81.06% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.